Eli Lilly & Co. (LLY) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
"main_header": {
"sid": 1156956,
"name": "Eli Lilly & Co.",
"stock_name": "Eli Lilly & Co.",
"full_name": "Eli Lilly & Co.",
"name_url": "stocks-analysis/eli-lilly-co",
"exchange": 207,
"exchangecode": "NYS",
"country_id": 2,
"currency": "USD",
"cmp": "1,014.49",
"chg": -19.07,
"chgp": "-1.85%",
"dir": -1,
"prev_price": "1,033.56",
"mcapval": "699,432.81",
"mcap": "Large Cap",
"scripcode": "",
"symbol": "",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 2305,
"indexname": "S&P 500",
"isin": "US5324571083",
"curr_date": "Dec 04",
"curr_time": "",
"bse_nse_vol": "7.71 M",
"exc_status": "Active",
"traded_date": "Dec 04, 2025",
"traded_date_str": "2025 12 04",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 0,
"is_blur": 1,
"is_blur_class": "blur-registerF-score-header",
"is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/eli-lilly-co-1156956-207&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [
{
"title": "Eli Lilly & Co. Reports Strong Financial Performance in Latest Quarter",
"link": "https://www.marketsmojo.com/news/mojo-premium/eli-lilly-co-enters-recommended-mojo-stocks-strategy-following-strong-financial-performance-3689976",
"imagepath": "",
"date": "2025-11-11 16:15:41",
"description": "Eli Lilly & Co. has demonstrated impressive financial results for the quarter ending June 2025, showcasing a robust operational performance that has caught the attention of investors. The company, recognized as a large-cap entity, has reported significant increases across various financial metrics, indicating a strong position in the market.\n\nOne of the standout figures from the report is the operating cash flow, which reached an all-time high of USD 10,938.2 MM. This substantial cash flow underscores the company's ability to generate liquidity and manage its operations effectively.\n\nAdditionally, the return on capital employed (ROCE) for the first half of the year was recorded at an impressive 86.7%, reflecting the efficiency with which the company utilizes its capital to generate profits. This high ROCE is a positive indicator for potential investors looking for companies..."
},
{
"title": "Is Eli Lilly & Co. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-eli-lilly-co-technically-bullish-or-bearish-3673560",
"imagepath": "",
"date": "2025-11-05 11:19:36",
"description": "As of 31 October 2025, the technical trend for Eli Lilly & Co. has changed from mildly bearish to mildly bullish. The weekly MACD and Bollinger Bands are bullish, while the monthly MACD is mildly bearish. The daily moving averages indicate a mildly bearish stance. Dow Theory shows a mildly bullish trend in both weekly and monthly perspectives. \n\nEli Lilly has outperformed the S&P 500 across multiple periods, with a 1-week return of 9.73% compared to 0.71% for the S&P 500, and a 3-year return of 150.74% versus 76.66%. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD and Bollinger Bands...."
},
{
"title": "Is Eli Lilly & Co. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-eli-lilly-co-technically-bullish-or-bearish-3670751",
"imagepath": "",
"date": "2025-11-04 11:31:03",
"description": "As of 31 October 2025, the technical trend for Eli Lilly & Co. changed from mildly bearish to mildly bullish. The weekly MACD is bullish, supported by bullish Bollinger Bands and a mildly bullish stance in Dow Theory. However, the monthly MACD and KST remain mildly bearish, indicating some caution. The daily moving averages are mildly bearish, and the weekly OBV is mildly bearish while the monthly OBV is bullish. Overall, the mixed signals suggest a mildly bullish stance, but with some underlying bearish indicators that could limit strength. Multi-period return data is not available for comparison with the S&P 500...."
},
{
"title": "Is Eli Lilly & Co. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-eli-lilly-co-technically-bullish-or-bearish-3666342",
"imagepath": "",
"date": "2025-11-03 11:30:11",
"description": "As of 31 October 2025, the technical trend for Eli Lilly & Co. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. The Bollinger Bands are bullish on both weekly and monthly charts, supporting the bullish stance. Moving averages are mildly bearish on the daily chart, which adds some caution. The Dow Theory shows a mildly bullish trend on both weekly and monthly bases, reinforcing the overall positive outlook.\n\nIn terms of performance, Eli Lilly has outperformed the S&P 500 over the past week and month, but it has lagged behind on a year-to-date and one-year basis. Over three and five years, the stock has significantly outperformed the benchmark. Overall, the current technical stance is mildly bullish, driven by the positive indicators from Bollinger Bands and Dow Theory, despite some mixed signa..."
},
{
"title": "Is Eli Lilly & Co. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-eli-lilly-co-technically-bullish-or-bearish-3664458",
"imagepath": "",
"date": "2025-11-02 11:16:11",
"description": "As of 31 October 2025, the technical trend for Eli Lilly & Co. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, supported by bullish Bollinger Bands and a mildly bullish stance in Dow Theory. However, the monthly MACD and KST remain mildly bearish, indicating some caution. The daily moving averages are mildly bearish, and the OBV shows a mixed signal with a bullish monthly reading. \n\nIn terms of performance, Eli Lilly has outperformed the S&P 500 over the past week and month, but it lags behind the benchmark on a year-to-date and one-year basis. Overall, the current technical stance is mildly bullish, driven primarily by the weekly indicators...."
},
{
"title": "Eli Lilly Hits Day High with 3.81% Surge, Showcasing Strong Performance",
"link": "https://www.marketsmojo.com/news/stocks-in-action/eli-lilly-hits-day-high-with-381-surge-showcasing-strong-performance-3662080",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/EliLillyCo_priceRelatedfactors_3662080.png",
"date": "2025-10-31 16:53:38",
"description": "Eli Lilly & Co. has seen significant gains today, reaching an intraday high and outperforming the S&P 500. Over the past month, the company has shown strong growth, with impressive long-term performance metrics, including high return on capital and effective debt management, alongside consistent positive quarterly results."
},
{
"title": "Eli Lilly & Co. Experiences Evaluation Revision Amidst Mixed Market Signals and Performance",
"link": "https://www.marketsmojo.com/news/stocks-in-action/eli-lilly-co-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-stock-price-increase-3652022",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/EliLillyCo_technicaldot_3652022.png",
"date": "2025-10-28 15:23:07",
"description": "Eli Lilly & Co. has recently revised its evaluation amid fluctuating market conditions. The stock is currently priced at $826.41, reflecting notable volatility over the past year. Technical indicators present mixed signals, while the company's performance has varied compared to the S&P 500 across different time frames."
},
{
"title": "Is Eli Lilly & Co. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-eli-lilly-co-technically-bullish-or-bearish-3651313",
"imagepath": "",
"date": "2025-10-28 11:40:14",
"description": "As of 24 October 2025, the technical trend for Eli Lilly & Co. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. The Bollinger Bands are bullish on both weekly and monthly charts, supporting the mildly bullish stance. However, the daily moving averages are mildly bearish, which adds some caution. The KST shows a bullish weekly trend but is mildly bearish monthly, and the OBV is bullish monthly, suggesting accumulation. \n\nIn terms of performance, Eli Lilly has outperformed the S&P 500 over the past week and month, returning 2.82% and 11.27% respectively, while the S&P 500 returned 1.92% and 2.32%. However, year-to-date and one-year returns are lagging behind the benchmark. Overall, the current technical stance is mildly bullish, with key indicators such as the weekly MACD and Bollinger Bands driving ..."
},
{
"title": "Is Eli Lilly & Co. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-eli-lilly-co-technically-bullish-or-bearish-3647767",
"imagepath": "",
"date": "2025-10-27 11:51:23",
"description": "As of 24 October 2025, the technical trend for Eli Lilly & Co. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. The Bollinger Bands are bullish on both weekly and monthly charts, supporting the mildly bullish stance. However, the daily moving averages are mildly bearish, which tempers the overall bullish outlook. The KST shows a bullish signal weekly but is mildly bearish monthly, and the Dow Theory indicates a mildly bullish trend on a monthly basis. \n\nIn terms of performance, Eli Lilly has outperformed the S&P 500 over the past week and month, returning 2.82% and 11.27% respectively, but lags behind on a year-to-date and one-year basis. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD and Bollinger Bands...."
}
],
"total": 27,
"sid": "1156956",
"stock_news_url": "https://www.marketsmojo.com/news/eli-lilly-co-1156956"
},
"announcements": "",
"corporate_actions": {
"msg": "No corporate action Found"
}
}

News and Views

Eli Lilly & Co. Reports Strong Financial Performance in Latest Quarter

2025-11-11 16:15:41

Eli Lilly & Co. has demonstrated impressive financial results for the quarter ending June 2025, showcasing a robust operational performance that has caught the attention of investors. The company, recognized as a large-cap entity, has reported significant increases across various financial metrics, indicating a strong position in the market.

One of the standout figures from the report is the operating cash flow, which reached an all-time high of USD 10,938.2 MM. This substantial cash flow underscores the company's ability to generate liquidity and manage its operations effectively.

Additionally, the return on capital employed (ROCE) for the first half of the year was recorded at an impressive 86.7%, reflecting the efficiency with which the company utilizes its capital to generate profits. This high ROCE is a positive indicator for potential investors looking for companies...

Is Eli Lilly & Co. technically bullish or bearish?

2025-11-05 11:19:36

As of 31 October 2025, the technical trend for Eli Lilly & Co. has changed from mildly bearish to mildly bullish. The weekly MACD and Bollinger Bands are bullish, while the monthly MACD is mildly bearish. The daily moving averages indicate a mildly bearish stance. Dow Theory shows a mildly bullish trend in both weekly and monthly perspectives. Eli Lilly has outperformed the S&P 500 across multiple periods, with a 1-week return of 9.73% compared to 0.71% for the S&P 500, and a 3-year return of 150.74% versus 76.66%. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD and Bollinger Bands....

Is Eli Lilly & Co. technically bullish or bearish?

2025-11-04 11:31:03

As of 31 October 2025, the technical trend for Eli Lilly & Co. changed from mildly bearish to mildly bullish. The weekly MACD is bullish, supported by bullish Bollinger Bands and a mildly bullish stance in Dow Theory. However, the monthly MACD and KST remain mildly bearish, indicating some caution. The daily moving averages are mildly bearish, and the weekly OBV is mildly bearish while the monthly OBV is bullish. Overall, the mixed signals suggest a mildly bullish stance, but with some underlying bearish indicators that could limit strength. Multi-period return data is not available for comparison with the S&P 500....

Is Eli Lilly & Co. technically bullish or bearish?

2025-11-03 11:30:11

As of 31 October 2025, the technical trend for Eli Lilly & Co. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. The Bollinger Bands are bullish on both weekly and monthly charts, supporting the bullish stance. Moving averages are mildly bearish on the daily chart, which adds some caution. The Dow Theory shows a mildly bullish trend on both weekly and monthly bases, reinforcing the overall positive outlook. In terms of performance, Eli Lilly has outperformed the S&P 500 over the past week and month, but it has lagged behind on a year-to-date and one-year basis. Over three and five years, the stock has significantly outperformed the benchmark. Overall, the current technical stance is mildly bullish, driven by the positive indicators from Bollinger Bands and Dow Theory, despite some mixed signa...

Is Eli Lilly & Co. technically bullish or bearish?

2025-11-02 11:16:11

As of 31 October 2025, the technical trend for Eli Lilly & Co. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, supported by bullish Bollinger Bands and a mildly bullish stance in Dow Theory. However, the monthly MACD and KST remain mildly bearish, indicating some caution. The daily moving averages are mildly bearish, and the OBV shows a mixed signal with a bullish monthly reading. In terms of performance, Eli Lilly has outperformed the S&P 500 over the past week and month, but it lags behind the benchmark on a year-to-date and one-year basis. Overall, the current technical stance is mildly bullish, driven primarily by the weekly indicators....

Eli Lilly Hits Day High with 3.81% Surge, Showcasing Strong Performance

2025-10-31 16:53:38

Eli Lilly & Co. has seen significant gains today, reaching an intraday high and outperforming the S&P 500. Over the past month, the company has shown strong growth, with impressive long-term performance metrics, including high return on capital and effective debt management, alongside consistent positive quarterly results.

Eli Lilly & Co. Experiences Evaluation Revision Amidst Mixed Market Signals and Performance

2025-10-28 15:23:07

Eli Lilly & Co. has recently revised its evaluation amid fluctuating market conditions. The stock is currently priced at $826.41, reflecting notable volatility over the past year. Technical indicators present mixed signals, while the company's performance has varied compared to the S&P 500 across different time frames.

Is Eli Lilly & Co. technically bullish or bearish?

2025-10-28 11:40:14

As of 24 October 2025, the technical trend for Eli Lilly & Co. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. The Bollinger Bands are bullish on both weekly and monthly charts, supporting the mildly bullish stance. However, the daily moving averages are mildly bearish, which adds some caution. The KST shows a bullish weekly trend but is mildly bearish monthly, and the OBV is bullish monthly, suggesting accumulation. In terms of performance, Eli Lilly has outperformed the S&P 500 over the past week and month, returning 2.82% and 11.27% respectively, while the S&P 500 returned 1.92% and 2.32%. However, year-to-date and one-year returns are lagging behind the benchmark. Overall, the current technical stance is mildly bullish, with key indicators such as the weekly MACD and Bollinger Bands driving ...

Is Eli Lilly & Co. technically bullish or bearish?

2025-10-27 11:51:23

As of 24 October 2025, the technical trend for Eli Lilly & Co. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. The Bollinger Bands are bullish on both weekly and monthly charts, supporting the mildly bullish stance. However, the daily moving averages are mildly bearish, which tempers the overall bullish outlook. The KST shows a bullish signal weekly but is mildly bearish monthly, and the Dow Theory indicates a mildly bullish trend on a monthly basis. In terms of performance, Eli Lilly has outperformed the S&P 500 over the past week and month, returning 2.82% and 11.27% respectively, but lags behind on a year-to-date and one-year basis. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD and Bollinger Bands....

View All News